SCHEMBL32690779

SCHEMBL32690779

COC(=O)CCCCC(=O)Nc1cccc2[nH]c(-c3ccccc3C(F)(F)F)c(O)c(=O)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPRC P08575 4/20 0.41
▸ PTPN13 Q12923 2/20 0.41
▸ CYP1A2 P05177 3/20 0.41
▸ CYP2C19 P33261 3/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ PARP14 Q460N5 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ POLB P06746 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ HPGD P15428 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ HDAC3 O15379 1/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC7 Q8WUI4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32690814 0.99 PTPRC (0.41) PTPRCPTPN13CYP1A2CYP2C19CYP3A4
SCHEMBL32690735 0.99 PTPRC (0.41) PTPRCPTPN13CYP1A2CYP2C19CYP3A4
SCHEMBL32690839 0.99 PTPRC (0.41) PTPRCPTPN13CYP1A2CYP2C19CYP3A4
SCHEMBL32690837 0.90 HDAC1 (0.41) CYP1A2CYP2C19CYP3A4CYP2D6MEN1
SCHEMBL32690653 0.89 HDAC1 (0.42) CYP1A2CYP2C19CYP3A4CYP2D6MEN1
SCHEMBL32690776 0.89 HDAC1 (0.42) CYP1A2CYP2C19CYP3A4CYP2D6MEN1
SCHEMBL32690650 0.89 HDAC1 (0.42) CYP1A2CYP2C19CYP3A4CYP2D6MEN1
SCHEMBL32690797 0.88 PARP14 (0.42) PTPRCPTPN13CYP1A2CYP2C19CYP3A4
SCHEMBL32690684 0.88 PARP14 (0.41) PTPRCPTPN13CYP1A2CYP2C19CYP3A4
SCHEMBL32690781 0.88 PARP14 (0.41) PTPRCPTPN13CYP1A2CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition TAIWANJ PHARMACEUTICALS CO LTD (TW) 2026-03-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition NOX1, NOX4, CYBB PTPRC 436/4885PTPN13 944/4885CYP1A2 1001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback